SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Chun Yang, Ye-xiong Tan, Guang-zhen Yang, Jian Zhang, Yu-fei Pan, Chen Liu, Jing Fu, Yao Chen, Zhi-wen Ding, Li-wei Dong, Hong-yang Wang, Gankyrin has an antioxidative role through the feedback regulation of Nrf2 in hepatocellular carcinoma, The Journal of Experimental Medicine, 2016, jem.20151208

    CrossRef

  2. 2
    Genta Sawada, Atsushi Niida, Ryutaro Uchi, Hidenari Hirata, Teppei Shimamura, Yutaka Suzuki, Yuichi Shiraishi, Kenichi Chiba, Seiya Imoto, Yusuke Takahashi, Takeshi Iwaya, Tomoya Sudo, Tomoatsu Hayashi, Hiroki Takai, Yoshihiro Kawasaki, Takashi Matsukawa, Hidetoshi Eguchi, Keishi Sugimachi, Fumiaki Tanaka, Hiromichi Suzuki, Ken Yamamoto, Hideshi Ishii, Makiko Shimizu, Hiroshi Yamazaki, Makoto Yamazaki, Yuji Tachimori, Yoshiaki Kajiyama, Shoji Natsugoe, Hiromasa Fujita, Kenichi Mafune, Yoichi Tanaka, David P. Kelsell, Claire A. Scott, Shoji Tsuji, Shinichi Yachida, Tatsuhiro Shibata, Sumio Sugano, Yuichiro Doki, Tetsu Akiyama, Hiroyuki Aburatani, Seishi Ogawa, Satoru Miyano, Masaki Mori, Koshi Mimori, Genomic Landscape of Esophageal Squamous Cell Carcinoma in a Japanese Population, Gastroenterology, 2016, 150, 5, 1171

    CrossRef

  3. 3
    Takayoshi Kishino, Tohru Niwa, Satoshi Yamashita, Takamasa Takahashi, Hidetsugu Nakazato, Takeshi Nakajima, Hiroyasu Igaki, Yuji Tachimori, Yasuyuki Suzuki, Toshikazu Ushijima, Integrated analysis of DNA methylation and mutations in esophageal squamous cell carcinoma, Molecular Carcinogenesis, 2016, 55, 5
  4. 4
    C Deng, B Zhang, S Zhang, C Duan, Y Cao, W Kang, H Yan, X Ding, F Zhou, L Wu, G Duan, S Shen, G Xu, W Zhang, M Chen, S Huang, X Zhang, Y Lv, T Ling, L Wang, X Zou, Low nanomolar concentrations of Cucurbitacin-I induces G2/M phase arrest and apoptosis by perturbing redox homeostasis in gastric cancer cells in vitro and in vivo, Cell Death and Disease, 2016, 7, 2, e2106

    CrossRef

  5. 5
    In-geun Ryoo, Sang-hwan Lee, Mi-Kyoung Kwak, Redox Modulating NRF2: A Potential Mediator of Cancer Stem Cell Resistance, Oxidative Medicine and Cellular Longevity, 2016, 2016, 1

    CrossRef

  6. 6
    Agnieszka Loboda, Milena Damulewicz, Elzbieta Pyza, Alicja Jozkowicz, Jozef Dulak, Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism, Cellular and Molecular Life Sciences, 2016,

    CrossRef

  7. 7
    Stéphanie Anaís Castaldo, Joana Raquel Freitas, Nadine Vasconcelos Conchinha, Patrícia Alexandra Madureira, The Tumorigenic Roles of the Cellular REDOX Regulatory Systems, Oxidative Medicine and Cellular Longevity, 2016, 2016, 1

    CrossRef

  8. 8
    Hye-Youn Cho, Steven R. Kleeberger, Association of Nrf2 with airway pathogenesis: lessons learned from genetic mouse models, Archives of Toxicology, 2015, 89, 11, 1931

    CrossRef

  9. 9
    Hye-Youn Cho, Anne E. Jedlicka, Wesley Gladwell, Jacqui Marzec, Zackary R. McCaw, Rachelle J. Bienstock, Steven R. Kleeberger, Association ofNrf2Polymorphism Haplotypes with Acute Lung Injury Phenotypes in Inbred Strains of Mice, Antioxidants & Redox Signaling, 2015, 22, 4, 325

    CrossRef

  10. 10
    Yu Kigoshi, Tomomi Fukuda, Tomoyuki Endo, Nami Hayasaka, Shun-ichiro Iemura, Toru Natsume, Fuminori Tsuruta, Tomoki Chiba, CACUL1/CAC1 Regulates the Antioxidant Response by Stabilizing Nrf2, Scientific Reports, 2015, 5, 12857

    CrossRef

  11. 11
    Yota Kawasaki, Sumiya Ishigami, Takaaki Arigami, Yoshikazu Uenosono, Shigehiro Yanagita, Yasuto Uchikado, Yoshiaki Kita, Yuka Nishizono, Hiroshi Okumura, Akihiro Nakajo, Yuko Kijima, Kosei Maemura, Shoji Natsugoe, Clinicopathological significance of nuclear factor (erythroid-2)-related factor 2 (Nrf2) expression in gastric cancer, BMC Cancer, 2015, 15, 1, 5

    CrossRef

  12. 12
    Hongyu Zheng, Zhiwei Nong, Guohao Lu, Correlation Between Nuclear Factor E2-Related Factor 2 Expression and Gastric Cancer Progression, Medical Science Monitor, 2015, 21, 2893

    CrossRef

  13. 13
    Chandra B Lebovitz, A Gordon Robertson, Rodrigo Goya, Steven J Jones, Ryan D Morin, Marco A Marra, Sharon M Gorski, Cross-cancer profiling of molecular alterations within the human autophagy interaction network, Autophagy, 2015, 11, 9, 1668

    CrossRef

  14. 14
    Eric Habib, Katja Linher-Melville, Han-Xin Lin, Gurmit Singh, Expression of xCT and activity of system xc− are regulated by NRF2 in human breast cancer cells in response to oxidative stress, Redox Biology, 2015, 5, 33

    CrossRef

  15. 15
    Mi Ryoung Choi, Nam Jin Yoo, Chang Hyeok An, Sug Hyung Lee, Frameshift mutations in mammalian target of rapamycin pathway genes and their regional heterogeneity in sporadic colorectal cancers, Human Pathology, 2015, 46, 5, 753

    CrossRef

  16. 16
    Chang Hyeok An, Eun Mi Je, Nam Jin Yoo, Sug Hyung Lee, Frameshift Mutations of Cadherin Genes DCHS2, CDH10 and CDH24 Genes in Gastric and Colorectal Cancers with High Microsatellite Instability, Pathology & Oncology Research, 2015, 21, 1, 181

    CrossRef

  17. 17
    Hye-Youn Cho, Jacqui Marzec, Steven R. Kleeberger, Functional polymorphisms in Nrf2: implications for human disease, Free Radical Biology and Medicine, 2015, 88, 362

    CrossRef

  18. 18
    Ying-Hui Tong, Bo Zhang, Yun Fan, Neng-Ming Lin, Keap1–Nrf2 pathway: A promising target towards lung cancer prevention and therapeutics, Chronic Diseases and Translational Medicine, 2015, 1, 3, 175

    CrossRef

  19. 19
    Lauren E. Tebay, Holly Robertson, Stephen T. Durant, Steven R. Vitale, Trevor M. Penning, Albena T. Dinkova-Kostova, John D. Hayes, Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease, Free Radical Biology and Medicine, 2015, 88, 108

    CrossRef

  20. 20
    Takafumi Suzuki, Masayuki Yamamoto, Molecular basis of the Keap1–Nrf2 system, Free Radical Biology and Medicine, 2015, 88, 93

    CrossRef

  21. 21
    Velio Bocci, Giuseppe Valacchi, Nrf2 activation as target to implement therapeutic treatments, Frontiers in Chemistry, 2015, 3,

    CrossRef

  22. 22
    Gina M DeNicola, Pei-Hsuan Chen, Edouard Mullarky, Jessica A Sudderth, Zeping Hu, David Wu, Hao Tang, Yang Xie, John M Asara, Kenneth E Huffman, Ignacio I Wistuba, John D Minna, Ralph J DeBerardinis, Lewis C Cantley, NRF2 regulates serine biosynthesis in non–small cell lung cancer, Nature Genetics, 2015, 47, 12, 1475

    CrossRef

  23. 23
    N M Shah, L Zaitseva, K M Bowles, D J MacEwan, S A Rushworth, NRF2-driven miR-125B1 and miR-29B1 transcriptional regulation controls a novel anti-apoptotic miRNA regulatory network for AML survival, Cell Death and Differentiation, 2015, 22, 4, 654

    CrossRef

  24. 24
    Matthias Schäfer, Sabine Werner, Nrf2—A regulator of keratinocyte redox signaling, Free Radical Biology and Medicine, 2015, 88, 243

    CrossRef

  25. 25
    Shasha Tao, Sophia L. Park, Montserrat Rojo de la Vega, Donna D. Zhang, Georg T. Wondrak, Systemic administration of the apocarotenoid bixin protects skin against solar UV-induced damage through activation of NRF2, Free Radical Biology and Medicine, 2015, 89, 690

    CrossRef

  26. 26
    Ying Huang, Wenji Li, Zheng-yuan Su, Ah-Ng Tony Kong, The complexity of the Nrf2 pathway: beyond the antioxidant response, The Journal of Nutritional Biochemistry, 2015, 26, 12, 1401

    CrossRef

  27. 27
    Agnieszka Gęgotek, Elżbieta Skrzydlewska, The role of transcription factor Nrf2 in skin cells metabolism, Archives of Dermatological Research, 2015, 307, 5, 385

    CrossRef

  28. 28
    Chenguang Li, Zhibo Gao, Fei Li, Xiangchun Li, Yihua Sun, Mengyun Wang, Dan Li, Rui Wang, Fuming Li, Rong Fang, Yunjian Pan, Xiaoyang Luo, Jing He, Liangtao Zheng, Jufeng Xia, Lixin Qiu, Jun He, Ting Ye, Ruoxin Zhang, Minghui He, Meiling Zhu, Haichuan Hu, Tingyan Shi, Xiaoyan Zhou, Menghong Sun, Shilin Tian, Yong Zhou, Qiaoxiu Wang, Longyun Chen, Guangliang Yin, Jingya Lu, Renhua Wu, Guangwu Guo, Yingrui Li, Xueda Hu, Lin Li, Asan, Qin Wang, Ye Yin, Qiang Feng, Bin Wang, Hang Wang, Mingbang Wang, Xiaonan Yang, Xiuqing Zhang, Huanming Yang, Li Jin, Cun-Yu Wang, Hongbin Ji, Haiquan Chen, Jun Wang, Qingyi Wei, Whole Exome Sequencing Identifies Frequent Somatic Mutations in Cell-Cell Adhesion Genes in Chinese Patients with Lung Squamous Cell Carcinoma, Scientific Reports, 2015, 5, 14237

    CrossRef

  29. 29
    Françoise Guéraud, Lipid Oxidation in Health and Disease, 2015,

    CrossRef

  30. 30
    Svitlana Kurinna, Matthias Schäfer, Paola Ostano, Emmanuel Karouzakis, Giovanna Chiorino, Wilhelm Bloch, Andreas Bachmann, Steffen Gay, David Garrod, Karine Lefort, Gian-Paolo Dotto, Hans-Dietmar Beer, Sabine Werner, A novel Nrf2-miR-29-desmocollin-2 axis regulates desmosome function in keratinocytes, Nature Communications, 2014, 5, 5099

    CrossRef

  31. 31
    H. Shen, Y. Yang, S. Xia, B. Rao, J. Zhang, J. Wang, Blockage of Nrf2 suppresses the migration and invasion of esophageal squamous cell carcinoma cells in hypoxic microenvironment, Diseases of the Esophagus, 2014, 27, 7
  32. 32
    Chang Yong Choi, Jin Young Kim, Seo Yeong Wee, Jang Hyun Lee, Doo Hyun Nam, Chul Han Kim, Moon Kyun Cho, Yoon Jin Lee, Hae Seon Nam, Sang Han Lee, Sung Woo Cho, Expression of Nuclear Factor Erythroid 2 Protein in Malignant Cutaneous Tumors, Archives of Plastic Surgery, 2014, 41, 6, 654

    CrossRef

  33. 33
    Youn Jin Choi, Hye Rim Oh, Mi Ryoung Choi, Min Gwak, Chang Hyeok An, Yeun Jun Chung, Nam Jin Yoo, Sug Hyung Lee, Frameshift mutation of a histone methylation-related gene SETD1B and its regional heterogeneity in gastric and colorectal cancers with high microsatellite instability, Human Pathology, 2014, 45, 8, 1674

    CrossRef

  34. 34
    Akhileshwar Namani, Yulong Li, Xiu Jun Wang, Xiuwen Tang, Modulation of NRF2 signaling pathway by nuclear receptors: Implications for cancer, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2014, 1843, 9, 1875

    CrossRef

  35. 35
    Mi Ryoung Choi, Chang Hyeok An, Yeun Jun Chung, Youn Jin Choi, Nam Jin Yoo, Sug Hyung Lee, Mutational and expressional analysis of ERBB3 gene in common solid cancers, APMIS, 2014, 122, 12
  36. 36
    Eun Mi Je, Nam Jin Yoo, Sug Hyung Lee, Mutational and expressional analysis of SMC2 gene in gastric and colorectal cancers with microsatellite instability, APMIS, 2014, 122, 6
  37. 37
    Monique G.P. van der Wijst, Robert Brown, Marianne G. Rots, Nrf2, the master redox switch: The Achilles' heel of ovarian cancer?, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2014, 1846, 2, 494

    CrossRef

  38. 38
    MingJun Xiang, Akhileshwar Namani, ShiJun Wu, XiaoLi Wang, Nrf2: bane or blessing in cancer?, Journal of Cancer Research and Clinical Oncology, 2014, 140, 8, 1251

    CrossRef

  39. 39
    Hye-Kyung Na, Young-Joon Surh, Oncogenic potential of Nrf2 and its principal target protein heme oxygenase-1, Free Radical Biology and Medicine, 2014, 67, 353

    CrossRef

  40. 40
    Jiaguo Wu, Hongyan Wang, Xiuwen Tang, Rexinoid inhibits Nrf2-mediated transcription through retinoid X receptor alpha, Biochemical and Biophysical Research Communications, 2014, 452, 3, 554

    CrossRef

  41. 41
    Andrea Glasauer, Navdeep S. Chandel, Targeting antioxidants for cancer therapy, Biochemical Pharmacology, 2014, 92, 1, 90

    CrossRef

  42. 42
    Jae Hong No, Yong-Beom Kim, Yong Sang Song, Targeting Nrf2 Signaling to Combat Chemoresistance, Journal of Cancer Prevention, 2014, 19, 2, 111

    CrossRef

  43. 43
    Annette Hayden, James Douglas, Matthew Sommerlad, Lawrence Andrews, Katherine Gould, Syed Hussain, Gareth J. Thomas, Graham Packham, Simon J. Crabb, The Nrf2 transcription factor contributes to resistance to cisplatin in bladder cancer, Urologic Oncology: Seminars and Original Investigations, 2014, 32, 6, 806

    CrossRef

  44. 44
    Ana I. Rojo, Patricia Rada, Marta Mendiola, Ana Ortega-Molina, Katarzyna Wojdyla, Adelina Rogowska-Wrzesinska, David Hardisson, Manuel Serrano, Antonio Cuadrado, The PTEN/NRF2 Axis Promotes Human Carcinogenesis, Antioxidants & Redox Signaling, 2014, 21, 18, 2498

    CrossRef

  45. 45
    Daniel SW Tan, Weining Wang, Hui Leong, Pui Sew, Dawn P Lau, Fui Chong, Sai Krisna, Tony KH Lim, N Iyer, Tongue carcinoma infrequently harbor common actionable genetic alterations, BMC Cancer, 2014, 14, 1, 679

    CrossRef

  46. 46
    Victor D. Martinez, Emily A. Vucic, Kelsie L. Thu, Larissa A. Pikor, Roland Hubaux, Wan L. Lam, Unique Pattern of Component Gene Disruption in the NRF2 Inhibitor KEAP1/CUL3/RBX1 E3-Ubiquitin Ligase Complex in Serous Ovarian Cancer, BioMed Research International, 2014, 2014, 1

    CrossRef

  47. 47
    Hanna M. Leinonen, Emilia Kansanen, Petri Pölönen, Merja Heinäniemi, Anna-Liisa Levonen, Redox and Cancer Part A, 2014,

    CrossRef

  48. 48
    A Genomics-Based Classification of Human Lung Tumors, Science Translational Medicine, 2013, 5, 209, 209ra153

    CrossRef

  49. 49
    Alexandria Lau, Samantha A. Whitman, Melba C. Jaramillo, Donna D. Zhang, Arsenic-Mediated Activation of the Nrf2-Keap1 Antioxidant Pathway, Journal of Biochemical and Molecular Toxicology, 2013, 27, 2
  50. 50
    Jong Hun Lee, Tin Oo Khor, Limin Shu, Zheng-Yuan Su, Francisco Fuentes, Ah-Ng Tony Kong, Dietary phytochemicals and cancer prevention: Nrf2 signaling, epigenetics, and cell death mechanisms in blocking cancer initiation and progression, Pharmacology & Therapeutics, 2013, 137, 2, 153

    CrossRef

  51. 51
    Eun Mi Je, Min Gwak, Hyerim Oh, Mi Ryoung Choi, Youn Jin Choi, Sug Hyung Lee, Nam Jin Yoo, Frameshift mutations of axon guidance genes ROBO1 and ROBO2 in gastric and colorectal cancers with microsatellite instability, Pathology, 2013, 45, 7, 645

    CrossRef

  52. 52
    Min Sung Kim, Chang Hyeok An, Nam Jin Yoo, Sug Hyung Lee, Frameshift mutations of chromosome cohesion–related genes SGOL1 and PDS5B in gastric and colorectal cancers with high microsatellite instability, Human Pathology, 2013, 44, 10, 2234

    CrossRef

  53. 53
    Min Sung Kim, Sung Hak Lee, Nam Jin Yoo, Sug Hyung Lee, Frameshift mutations of tumor suppressor gene EP300 in gastric and colorectal cancers with high microsatellite instability, Human Pathology, 2013, 44, 10, 2064

    CrossRef

  54. 54
    Larissa A. Pikor, Varune R. Ramnarine, Stephen Lam, Wan L. Lam, Genetic alterations defining NSCLC subtypes and their therapeutic implications, Lung Cancer, 2013, 82, 2, 179

    CrossRef

  55. 55
    Hye-Youn Cho, Genomic Structure and Variation of Nuclear Factor (Erythroid-Derived 2)-Like 2, Oxidative Medicine and Cellular Longevity, 2013, 2013, 1

    CrossRef

  56. 56
    A Arlt, S Sebens, S Krebs, C Geismann, M Grossmann, M-L Kruse, S Schreiber, H Schäfer, Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity, Oncogene, 2013, 32, 40, 4825

    CrossRef

  57. 57
    Yusuke Sato, Tetsuichi Yoshizato, Yuichi Shiraishi, Shigekatsu Maekawa, Yusuke Okuno, Takumi Kamura, Teppei Shimamura, Aiko Sato-Otsubo, Genta Nagae, Hiromichi Suzuki, Yasunobu Nagata, Kenichi Yoshida, Ayana Kon, Yutaka Suzuki, Kenichi Chiba, Hiroko Tanaka, Atsushi Niida, Akihiro Fujimoto, Tatsuhiko Tsunoda, Teppei Morikawa, Daichi Maeda, Haruki Kume, Sumio Sugano, Masashi Fukayama, Hiroyuki Aburatani, Masashi Sanada, Satoru Miyano, Yukio Homma, Seishi Ogawa, Integrated molecular analysis of clear-cell renal cell carcinoma, Nature Genetics, 2013, 45, 8, 860

    CrossRef

  58. 58
    Chiara Gorrini, Isaac S. Harris, Tak W. Mak, Modulation of oxidative stress as an anticancer strategy, Nature Reviews Drug Discovery, 2013, 12, 12, 931

    CrossRef

  59. 59
    Eun Mi Je, Nam Jin Yoo, Yoo Jin Kim, Myung Shin Kim, Sug Hyung Lee, Mutational analysis of splicing machinery genes SF3B1, U2AF1 and SRSF2 in myelodysplasia and other common tumors, International Journal of Cancer, 2013, 133, 1
  60. 60
    Ioannis P. Trougakos, Fabiola Sesti, Eleni Tsakiri, Vassilis G. Gorgoulis, Non-enzymatic post-translational protein modifications and proteostasis network deregulation in carcinogenesis, Journal of Proteomics, 2013, 92, 274

    CrossRef

  61. 61
    Suna Zhou, Wenguang Ye, Qiuju Shao, Mingxin Zhang, Jun Liang, Nrf2 is a potential therapeutic target in radioresistance in human cancer, Critical Reviews in Oncology/Hematology, 2013, 88, 3, 706

    CrossRef

  62. 62
    Irene Gañán-Gómez, Yue Wei, Hui Yang, María Carmen Boyano-Adánez, Guillermo García-Manero, Oncogenic functions of the transcription factor Nrf2, Free Radical Biology and Medicine, 2013, 65, 750

    CrossRef

  63. 63
    Venus Sosa, Teresa Moliné, Rosa Somoza, Rosanna Paciucci, Hiroshi Kondoh, Matilde E. LLeonart, Oxidative stress and cancer: An overview, Ageing Research Reviews, 2013, 12, 1, 376

    CrossRef

  64. 64
    Qiang Ma, Role of Nrf2 in Oxidative Stress and Toxicity, Annual Review of Pharmacology and Toxicology, 2013, 53, 1, 401

    CrossRef

  65. 65
    Eun Mi Je, Nam Jin Yoo, Sug Hyung Lee, Somatic Mutation of PARK2 Tumor Suppressor Gene is not Common in Common Solid Cancers, Pathology & Oncology Research, 2013, 19, 3, 393

    CrossRef

  66. 66
    Alison K. Bauer, Thomas Hill, Carla-Maria Alexander, The Involvement of NRF2 in Lung Cancer, Oxidative Medicine and Cellular Longevity, 2013, 2013, 1

    CrossRef

  67. 67
    Shasha Tao, Rebecca Justiniano, Donna D. Zhang, Georg T. Wondrak, The Nrf2-inducers tanshinone I and dihydrotanshinone protect human skin cells and reconstructed human skin against solar simulated UV, Redox Biology, 2013, 1, 1, 532

    CrossRef

  68. 68
    Mingxing Lei, Tian Yang, Xiangdong Lai, Xiufeng Bai, Weiming Qiu, Xiaohua Lian, Li Yang, Upregulation of interfollicular epidermal and hair infundibulum β-catenin expression in Gsdma3 mutant mice, Acta Histochemica, 2013, 115, 1, 63

    CrossRef

  69. 69
    Limin Shu, Chengyue Zhang, Ah-Ng Kong, Inflammation, Oxidative Stress, and Cancer, 2013,

    CrossRef

  70. You have full text access to this Open Access content70
    Daisuke Inoue, Takashi Suzuki, Yoichiro Mitsuishi, Yasuhiro Miki, Satoshi Suzuki, Shunichi Sugawara, Mika Watanabe, Akira Sakurada, Chiaki Endo, Akira Uruno, Hironobu Sasano, Takayuki Nakagawa, Kennichi Satoh, Nobuyuki Tanaka, Hiroshi Kubo, Hozumi Motohashi, Masayuki Yamamoto, Accumulation of p62/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma, Cancer Science, 2012, 103, 4
  71. 71
    Yan-Yi JIANG, Ming-Rong WANG, Chromosomal and genomic aberrations in esophageal squamous cell carcinoma, Hereditas (Beijing), 2012, 34, 5, 519

    CrossRef

  72. 72
    Rui Zhao, Yongyong Hou, Qiang Zhang, Courtney G. Woods, Peng Xue, Jingqi Fu, Kathy Yarborough, Dawei Guan, Melvin E. Andersen, Jingbo Pi, Cross-Regulations among NRFs and KEAP1 and Effects of their Silencing on Arsenic-Induced Antioxidant Response and Cytotoxicity in Human Keratinocytes, Environmental Health Perspectives, 2012, 120, 4, 583

    CrossRef

  73. 73
    Rebecca S. Heist, Lecia V. Sequist, Jeffrey A. Engelman, Genetic Changes in Squamous Cell Lung Cancer: A Review, Journal of Thoracic Oncology, 2012, 7, 5, 924

    CrossRef

  74. 74
    Agnieszka Loboda, Alicja Jozkowicz, Jozef Dulak, HIF-1 versus HIF-2 — Is one more important than the other?, Vascular Pharmacology, 2012, 56, 5-6, 245

    CrossRef

  75. 75
    Cécile Guichard, Giuliana Amaddeo, Sandrine Imbeaud, Yannick Ladeiro, Laura Pelletier, Ichrafe Ben Maad, Julien Calderaro, Paulette Bioulac-Sage, Mélanie Letexier, Françoise Degos, Bruno Clément, Charles Balabaud, Eric Chevet, Alexis Laurent, Gabrielle Couchy, Eric Letouzé, Fabien Calvo, Jessica Zucman-Rossi, Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma, Nature Genetics, 2012, 44, 6, 694

    CrossRef

  76. 76
    Yi Hu, Yanfang Ju, Dongmei Lin, Zhikuan Wang, Yurong Huang, Sujie Zhang, Chao Wu, Shunchang Jiao, Mutation of the Nrf2 gene in non-small cell lung cancer, Molecular Biology Reports, 2012, 39, 4, 4743

    CrossRef

  77. 77
    Michael B. Sporn, Karen T. Liby, NRF2 and cancer: the good, the bad and the importance of context, Nature Reviews Cancer, 2012, 12, 8, 564

    CrossRef

  78. 78
    Jae-Young Park, Youn Wha Kim, Yong-Koo Park, Nrf2 expression is associated with poor outcome in osteosarcoma, Pathology, 2012, 44, 7, 617

    CrossRef

  79. 79
    Sarala Manandhar, Bo-hyun Choi, Kyeong-Ah Jung, In-geun Ryoo, Mingu Song, Su Jin Kang, Han-Gon Choi, Jung-Ae Kim, Pil-Hoon Park, Mi-Kyoung Kwak, NRF2 inhibition represses ErbB2 signaling in ovarian carcinoma cells: Implications for tumor growth retardation and docetaxel sensitivity, Free Radical Biology and Medicine, 2012, 52, 9, 1773

    CrossRef

  80. 80
    Matthias Schäfer, Hany Farwanah, Ann-Helen Willrodt, Aaron J. Huebner, Konrad Sandhoff, Dennis Roop, Daniel Hohl, Wilhelm Bloch, Sabine Werner, Nrf2 links epidermal barrier function with antioxidant defense, EMBO Molecular Medicine, 2012, 4, 5
  81. 81
    Yoichiro Mitsuishi, Keiko Taguchi, Yukie Kawatani, Tatsuhiro Shibata, Toshihiro Nukiwa, Hiroyuki Aburatani, Masayuki Yamamoto, Hozumi Motohashi, Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming, Cancer Cell, 2012, 22, 1, 66

    CrossRef

  82. 82
    A M Bataille, J E Manautou, Nrf2: A Potential Target for New Therapeutics in Liver Disease, Clinical Pharmacology & Therapeutics, 2012, 92, 3
  83. 83
    Heta Merikallio, Paavo Pääkkö, Vuokko L. Kinnula, Terttu Harju, Ylermi Soini, Nuclear factor erythroid-derived 2-like 2 (Nrf2) and DJ1 are prognostic factors in lung cancer, Human Pathology, 2012, 43, 4, 577

    CrossRef

  84. 84
    Anna Lisa Furfaro, José Raúl Zumba Macay, Barbara Marengo, Mariapaola Nitti, Alessia Parodi, Daniela Fenoglio, Umberto Maria Marinari, Maria Adelaide Pronzato, Cinzia Domenicotti, Nicola Traverso, Resistance of neuroblastoma GI-ME-N cell line to glutathione depletion involves Nrf2 and heme oxygenase-1, Free Radical Biology and Medicine, 2012, 52, 2, 488

    CrossRef

  85. 85
    Nam Jin Yoo, Hyung Ran Kim, Yoo Ri Kim, Chang Hyeok An, Sug Hyung Lee, Somatic mutations of the KEAP1 gene in common solid cancers, Histopathology, 2012, 60, 6
  86. 86
    Alexander Drilon, Natasha Rekhtman, Marc Ladanyi, Paul Paik, Squamous-cell carcinomas of the lung: emerging biology, controversies, and the promise of targeted therapy, The Lancet Oncology, 2012, 13, 10, e418

    CrossRef

  87. 87
    A Arlt, H Schäfer, H Kalthoff, The ‘N-factors’ in pancreatic cancer: functional relevance of NF-κB, NFAT and Nrf2 in pancreatic cancer, Oncogenesis, 2012, 1, 11, e35

    CrossRef

  88. 88
    Emilie E. Vomhof-DeKrey, Matthew J. Picklo, The Nrf2-antioxidant response element pathway: a target for regulating energy metabolism, The Journal of Nutritional Biochemistry, 2012, 23, 10, 1201

    CrossRef

  89. 89
    Albena T. Dinkova-Kostova, The Role of Sulfhydryl Reactivity of Small Molecules for the Activation of the KEAP1/NRF2 Pathway and the Heat Shock Response, Scientifica, 2012, 2012, 1

    CrossRef

  90. 90
    Regina Brigelius-Flohé, Mike Müller, Doris Lippmann, Anna Patricia Kipp, The Yin and Yang of Nrf2-Regulated Selenoproteins in Carcinogenesis, International Journal of Cell Biology, 2012, 2012, 1

    CrossRef

  91. 91
    Ian M. Copple, Current Concepts in Drug Metabolism and Toxicology, 2012,

    CrossRef

  92. 92
    Tze Fang Wong, Kousuke Yoshinaga, Yasutake Monma, Kiyoshi Ito, Hitoshi Niikura, Satoru Nagase, Masayuki Yamamoto, Nobuo Yaegashi, Association of Keap1 and Nrf2 Genetic Mutations and Polymorphisms With Endometrioid Endometrial Adenocarcinoma Survival, International Journal of Gynecological Cancer, 2011, 21, 8, 1428

    CrossRef

  93. 93
    D. Ren, N. F. Villeneuve, T. Jiang, T. Wu, A. Lau, H. A. Toppin, D. D. Zhang, Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism, Proceedings of the National Academy of Sciences, 2011, 108, 4, 1433

    CrossRef

  94. 94
    Hong-Bo Wang, Cheng-Jun Zhou, Su-zhen Song, Peng Chen, Wei-hua Xu, Bin Liu, Kong-xi Zhu, Wei-hua Yu, Hong-lei Wu, Hong-juan Wang, Sen Lin, Jian-qiang Guo, Cheng-yong Qin, Evaluation of Nrf2 and IGF-1 expression in benign, premalignant and malignant gastric lesions, Pathology - Research and Practice, 2011, 207, 3, 169

    CrossRef

  95. 95
    Qing Kay Li, Anju Singh, Shyam Biswal, Frederic Askin, Edward Gabrielson, KEAP1 gene mutations and NRF2 activation are common in pulmonary papillary adenocarcinoma, Journal of Human Genetics, 2011, 56, 3, 230

    CrossRef

  96. 96
    V. O. Tkachev, E. B. Menshchikova, N. K. Zenkov, Mechanism of the Nrf2/Keap1/ARE signaling system, Biochemistry (Moscow), 2011, 76, 4, 407

    CrossRef

  97. You have free access to this content97
    Keiko Taguchi, Hozumi Motohashi, Masayuki Yamamoto, Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution, Genes to Cells, 2011, 16, 2
  98. 98
    Tatsuhiro Shibata, Akiko Kokubu, Shigeru Saito, Mako Narisawa-Saito, Hiroki Sasaki, Kazuhiko Aoyagi, Yuki Yoshimatsu, Yuji Tachimori, Ryoji Kushima, Tohru Kiyono, Masayuki Yamamoto, NRF2 Mutation Confers Malignant Potential and Resistance to Chemoradiation Therapy in Advanced Esophageal Squamous Cancer, Neoplasia, 2011, 13, 9, 864

    CrossRef

  99. 99
    Stephen L. Slocum, Thomas W. Kensler, Nrf2: control of sensitivity to carcinogens, Archives of Toxicology, 2011, 85, 4, 273

    CrossRef

  100. 100
    Akira Uruno, Hozumi Motohashi, The Keap1–Nrf2 system as an in vivo sensor for electrophiles, Nitric Oxide, 2011, 25, 2, 153

    CrossRef

  101. 101
    Nicole F. Villeneuve, Alexandria Lau, Donna D. Zhang, Regulation of the Nrf2–Keap1 Antioxidant Response by the Ubiquitin Proteasome System: An Insight into Cullin-Ring Ubiquitin Ligases, Antioxidants & Redox Signaling, 2010, 13, 11, 1699

    CrossRef

  102. 102
    Donna D. Zhang, The Nrf2-Keap1-ARE Signaling Pathway: The Regulation and Dual Function of Nrf2 in Cancer, Antioxidants & Redox Signaling, 2010, 13, 11, 1623

    CrossRef

  103. 103
    Masanobu Morita, Hozumi Motohashi, Survival Strategy and Disease Pathogenesis According to the Nrf2-Small Maf Heterodimer,